Annual Report

Overview

The report highlights Zydus's COVID-19 response, including permission to begin Adaptive Phase I/II human clinical trials for its vaccine. Consolidated revenue from operations was INR 142,531 million for the year ended March 31, 2020. The report also says organization-wide EHS programs led to zero fatalities in the safety area.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019-2020
Period: 1 April 2019 – 31 March 2020
Publication date: 19 June 2020
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services